Comments on:Benefits and risks of bisphosphonate therapy for osteoporosis / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 951-952, 2012.
Artículo
en Chino
| WPRIM
| ID: wpr-430353
ABSTRACT
Bisphosphonate,as a first line medicine for treating osteoporosis,has been efficacious in reducing the incidences of fractures and some tumors.Although severe side effects such as osteonecrosis of the jaw (ONJ) and atypical fracture of femur would take place,its very low incidence does not affect the current status of bisphosphonates in the treatment of osteoporosis.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio de etiología
Idioma:
Chino
Revista:
Chinese Journal of Endocrinology and Metabolism
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS